Pulmonx Corp

LUNG

Pulmonx Corp

LUNG

Insider Sentiment (TTM):

Last Purchase:2025-06-05Last Sale:2026-06-02Shares Purchased (TTM):0Shares Sold (TTM):231,512

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:30,937,187Shares Outstanding:41,897,669Institutional Ownership Pct.:73.84%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	56	62	70	77	75	75	71	63	63	70	84	95
Restricted Cash	0	0	0	0	0	0	0	0	0	0	0	0
Debt Securities Available For Sale Excluding Accru…	-	-	0	0	9	14	31	44	51	46	34	22
Accounts Receivable Net Current	12	11	12	14	16	14	13	12	11	11	12	10
Inventory Net	16	16	16	16	16	17	17	17	17	17	17	16
Prepaid Expense And Other Assets Current	3	4	4	4	3	4	4	4	3	4	4	4
Assets Current	88	93	102	111	120	124	136	141	146	148	150	147
Debt Securities Available For Sale Excluding Accru…	-	-	-	-	-	-	0	0	0	4	14	23
Inventory Noncurrent	4	4	4	2	2	1	2	2	2	3	3	3
Property Plant And Equipment Net	2	2	2	2	3	3	3	3	3	4	4	4
Goodwill	2	2	2	2	2	2	2	2	2	2	2	2
Operating Lease Right Of Use Asset	17	18	18	18	19	19	19	18	18	3	3	4
Finite Lived Intangible Assets Net	-	-	-	-	-	-	0	0	0	0	0	0
Other Assets Noncurrent	1	1	1	2	2	2	1	1	1	1	1	0
Assets	115	120	129	138	147	151	163	167	173	165	178	185
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	5	3	4	6	7	4	4	5	3	3	1	3
Accrued Liabilities Current	14	14	15	15	14	12	16	13	12	10	16	14
Accrued Income Taxes Current	0	0	0	0	0	0	0	0	0	0	0	0
Contract With Customer Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Short Term Borrowings	0	0	0	0	0	8	3	0	0	5	2	0
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	3	3	3
Liabilities Current	20	19	20	23	22	25	24	18	16	21	23	20
Deferred Income Tax Liabilities Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	17	18	18	18	19	19	19	18	18	1	1	2
Long Term Debt Noncurrent	37	37	37	37	37	29	34	37	37	32	35	37
Warrants And Rights Outstanding	0	0	-	-	-	-	-	-	-	-	-	-
Liabilities	76	74	75	78	78	73	77	73	71	54	59	59
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	582	579	573	569	564	557	551	546	539	533	527	521
Accumulated Other Comprehensive Income Loss Net Of…	2	2	2	2	3	2	2	3	2	2	3	2
Retained Earnings Accumulated Deficit	-545	-535	-522	-511	-497	-482	-468	-454	-440	-425	-411	-397
Stockholders Equity	39	46	54	60	69	78	86	94	101	110	118	126
Liabilities And Stockholders Equity	115	120	129	138	147	151	163	167	173	165	178	185
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	43	42	42	41	41	40	40	39	39	39	39	38
Shares Outstanding	43	42	42	41	41	40	40	39	39	39	39	38

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	24.06%	-6.02%	-12.03%	-	-	-	-	-	-	-	-	-
2025	-17.51%	-30.50%	-16.45%	4.97%	4.97%	-5.59%	2.55%	17.35%	-16.33%	-25.49%	-24.37%	-7.56%
2024	-17.82%	-36.66%	-19.35%	17.53%	34.27%	1.72%	8.29%	-1.91%	-0.16%	-10.48%	-47.93%	-60.48%
2023	-	-	-	-	-	-	11.39%	27.92%	31.15%	-8.99%	-25.79%	-11.07%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.32	4.91	5.07	4.86	5.35	4.97	5.58	7.70	8.97	6.95	6.50	7.19
Quick Ratio	3.35	3.84	4.09	3.96	4.47	4.13	4.70	6.54	7.72	5.96	5.59	6.19
Working Capital	67.73M	73.84M	81.63M	88.36M	97.57M	98.99M	111.81M	122.63M	129.86M	126.64M	127.27M	126.88M
Leverage & Debt
Debt to Equity	1.93	1.62	1.39	1.30	1.13	0.94	0.90	0.78	0.71	0.49	0.50	0.47
Interest Coverage TTM	-12.29	-15.54	-17.01	-17.72	-17.18	-16.95	-16.45	-16.31	-16.59	-16.95	-19.16	-23.31
Debt Ratio	0.66	0.62	0.58	0.57	0.53	0.48	0.47	0.44	0.41	0.33	0.33	0.32
Efficiency & Turnover
Asset Turnover TTM	0.67	0.65	0.62	0.60	0.57	0.55	0.49	0.45	0.42	0.40	0.37	0.33
Days Sales Outstanding TTM	58.75	51.13	50.80	50.70	54.38	51.11	54.94	50.08	47.71	46.74	55.23	48.74
Receivables Turnover TTM	6.21	7.14	7.18	7.20	6.71	7.14	6.64	7.29	7.65	7.81	6.61	7.49
Per Share Metrics
Diluted EPS TTM	-1.13	-1.27	-1.33	-1.39	-1.41	-1.43	-1.44	-1.45	-1.49	-1.52	-1.60	-1.61
Free Cash Flow Per Share TTM	-0.80	-0.71	-0.82	-0.48	-0.47	-0.86	-0.84	-0.89	-0.93	-0.98	-1.01	-1.04
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	77.06%	75.49%	74.19%	73.30%	73.07%	73.47%	74.00%	74.16%	74.19%	74.31%	73.90%	73.33%
Operating Profit Margin TTM	-52.96%	-58.79%	-59.30%	-62.38%	-62.85%	-66.00%	-68.87%	-73.40%	-77.37%	-82.30%	-90.19%	-96.64%
Net Profit Margin TTM	-55.03%	-60.09%	-59.67%	-61.91%	-62.88%	-65.27%	-67.30%	-72.01%	-75.56%	-80.46%	-88.60%	-94.47%
Growth Metrics
Net Revenue Growth (1Y)	-3.43%	1.23%	8.01%	15.59%	18.24%	19.84%	22.01%	22.34%	26.26%	27.14%	27.98%	24.79%
Net Income Growth (1Y)	-15.50%	-6.80%	-4.24%	-0.62%	-1.60%	-2.79%	-7.31%	-6.75%	-4.37%	-0.38%	3.26%	6.23%
EPS Growth (1Y)	-19.55%	-11.12%	-7.95%	-4.65%	-5.21%	-6.00%	-10.01%	-9.49%	-7.14%	-3.12%	0.87%	3.64%
Valuation Metrics
P/E TTM	-1.15	-1.02	-1.67	-1.17	-1.84	-4.71	-4.71	-5.70	-4.27	-6.10	-7.96	-6.43
P/B TTM	1.41	1.18	1.66	1.10	1.52	3.46	3.09	3.47	2.44	3.24	4.09	3.13
P/S TTM	0.63	0.61	0.99	0.72	1.16	3.07	3.17	4.11	3.22	4.91	7.05	6.07
Market Cap	55.21M	54.05M	89.92M	66.32M	104.71M	268.89M	265.56M	325.60M	246.90M	358.16M	484.18M	393.78M
Enterprise Value	36.90M	29.53M	57.00M	26.64M	66.10M	231.28M	231.58M	299.27M	220.38M	325.00M	437.64M	335.84M
Calculated Values
Free Cash Flow TTM	-34.10M	-29.92M	-33.33M	-19.55M	-18.96M	-34.26M	-32.98M	-34.79M	-36.25M	-37.96M	-38.42M	-39.75M
Net Debt	-18.31M	-24.52M	-32.91M	-39.68M	-38.61M	-37.62M	-33.98M	-26.33M	-26.52M	-33.16M	-46.54M	-57.94M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-02Sale

Owner: French, Glendon E. Iii

Title: President and CEO

Shares: 13,511

Price/Share: $1.57

Value: $21,212.27

Shares Owned: 1,178,162

Relationship: Director,Officer

Ownership: Direct

2026-06-01Sale

Owner: Rose, Geoffrey Beran

Title: CHIEF COMMERCIAL OFFICER

Shares: 8,023

Price/Share: $1.54

Value: $12,355.42

Shares Owned: 457,711

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: Lehman, David Aaron

Title: GENERAL COUNSEL

Shares: 14,594

Price/Share: $1.54

Value: $22,474.76

Shares Owned: 376,161

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: Radhakrishnan, Srikanth

Title: Chief Science &Techn. Officer

Shares: 14,497

Price/Share: $1.54

Value: $22,325.38

Shares Owned: 331,239

Relationship: Officer

Ownership: Direct

2026-03-02Sale

Owner: French, Glendon E. Iii

Title: President and CEO

Shares: 67,813

Price/Share: $1.43

Value: $96,972.59

Shares Owned: 1,409,511

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-02	French, Glendon E. Iii	Director,Officer	President and CEO	Direct	Sale	13,511	1.57	$21,212.27	1,178,162	4
2026-06-01	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	8,023	1.54	$12,355.42	457,711	4
2026-06-01	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	14,594	1.54	$22,474.76	376,161	4
2026-06-01	Radhakrishnan, Srikanth	Officer	Chief Science &Techn. Officer	Direct	Sale	14,497	1.54	$22,325.38	331,239	4
2026-03-02	French, Glendon E. Iii	Director,Officer	President and CEO	Direct	Sale	67,813	1.43	$96,972.59	1,409,511	4
2026-03-02	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	12,237	1.43	$17,498.91	240,755	4
2026-03-02	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	7,732	1.43	$11,056.76	365,734	4
2026-03-02	Radhakrishnan, Srikanth	Officer	Chief Science &Techn. Officer	Direct	Sale	10,483	1.43	$14,990.69	170,736	4
2025-12-08	Florin, Daniel P	Director	-	Direct	Sale	23,321	1.99	$46,408.79	93,910	4
2025-12-01	French, Glendon E. Iii	Director,Officer	President and CEO	Direct	Sale	8,805	1.57	$13,823.85	277,324	4
2025-12-01	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	6,322	1.57	$9,925.54	373,466	4
2025-12-01	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	10,278	1.57	$16,136.46	252,992	4
2025-09-02	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	9,769	1.60	$15,630.40	263,270	4
2025-09-02	Joshi, Mehul	Officer	Chief Financial Officer & PAO	Direct	Sale	7,936	1.60	$12,697.60	208,489	4
2025-09-02	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	6,543	1.60	$10,468.80	379,788	4
2025-09-02	Williamson, Steven S.	Director,Officer	PRESIDENT AND CEO	Direct	Sale	9,648	1.60	$15,436.80	358,967	4
2025-06-12	Ferrari, Richard	Director	-	Direct	Sale	8,000	3.16	$25,280.00	87,024	4
2025-06-05	Florin, Daniel P	Director	-	Direct	Purchase	23,321	3.06	$71,362.26	117,231	4
2025-06-02	Joshi, Mehul	Officer	Chief Financial Officer & PAO	Direct	Sale	8,061	3.13	$25,230.93	213,925	4
2025-06-02	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	6,947	3.13	$21,744.11	386,331	4
2025-06-02	Williamson, Steven S.	Director,Officer	PRESIDENT AND CEO	Direct	Sale	9,923	3.13	$31,058.99	366,115	4
2025-06-02	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	10,457	3.13	$32,730.41	273,039	4
2025-03-20	French, Glendon E. Iii	Director	-	Direct	Sale	20,000	7.85	$157,000.00	991,974	4
2025-03-03	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	5,779	7.12	$41,146.48	285,278	4
2025-03-03	Joshi, Mehul	Officer	Chief Financial Officer & PAO	Direct	Sale	14,384	7.12	$102,414.08	113,986	4
2025-03-03	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	22,355	7.31	$163,415.05	175,496	4
2025-03-03	Williamson, Steven S.	Director,Officer	PRESIDENT AND CEO	Direct	Sale	27,689	7.14	$197,699.46	194,342	4
2025-02-20	French, Glendon E. Iii	Director	-	Direct	Sale	55,453	8.45	$468,577.85	1,011,974	4
2025-01-17	French, Glendon E. Iii	Director	-	Direct	Sale	2,221	6.50	$14,436.50	1,067,427	4
2024-12-02	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	4,376	6.18	$27,043.68	291,057	4
2024-12-02	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	5,497	6.18	$33,971.46	197,851	4
2024-11-22	French, Glendon E. Iii	Director	-	Direct	Sale	20,000	6.63	$132,600.00	1,071,974	4
2024-10-17	French, Glendon E. Iii	Director	-	Direct	Sale	20,000	6.52	$130,400.00	1,091,974	4
2024-09-12	French, Glendon E. Iii	Director	-	Direct	Sale	20,000	8.09	$161,800.00	1,111,974	4
2024-09-03	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	5,765	6.70	$38,625.50	203,348	4
2024-09-03	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	4,586	6.70	$30,726.20	295,433	4
2024-08-20	Williamson, Steven S.	Director,Officer	PRESIDENT AND CEO	Direct	Purchase	14,245	6.84	$97,435.80	219,531	4
2024-06-24	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	1,184	6.16	$7,293.44	300,019	4
2024-06-03	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	5,475	6.97	$38,160.75	209,113	4
2024-06-03	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	4,297	6.97	$29,950.09	301,203	4
2024-05-22	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	1,184	8.71	$10,312.64	305,500	4
2024-04-22	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	1,184	7.49	$8,868.16	306,684	4
2024-03-22	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	1,184	9.36	$11,082.24	307,868	4
2024-03-01	Mckune, John	Officer	INTERIM CFO	Direct	Sale	1,078	9.06	$9,766.68	47,410	4
2024-03-01	Lehman, David Aaron	Officer	GENERAL COUNSEL	Direct	Sale	4,351	9.06	$39,420.06	145,488	4
2024-03-01	French, Glendon E. Iii	Director,Officer	PRESIDENT AND CEO	Direct	Sale	6,954	9.06	$63,003.24	1,116,758	4
2024-03-01	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	3,097	9.06	$28,058.82	239,952	4
2024-02-22	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	1,184	14.20	$16,812.80	243,049	4
2024-02-15	French, Glendon E. Iii	Director,Officer	PRESIDENT AND CEO	Direct	Sale	20,000	14.60	$292,000.00	1,121,344	4
2024-01-22	Rose, Geoffrey Beran	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	1,184	13.13	$15,545.92	244,233	4
2024-01-18	French, Glendon E. Iii	Director,Officer	PRESIDENT AND CEO	Direct	Sale	10,000	12.77	$127,700.00	1,141,344	4
2023-12-22	Rose, Geoffrey Beran	Officer	Chief Commercial Officer	Direct	Sale	1,184	12.75	$15,096.00	245,417	4
2023-12-21	French, Glendon E. Iii	Director,Officer	President and CEO	Direct	Sale	10,000	12.42	$124,200.00	1,151,344	4
2023-12-01	Rose, Geoffrey Beran	Officer	Chief Commercial Officer	Direct	Sale	2,868	10.34	$29,655.12	246,601	4
2023-12-01	French, Glendon E. Iii	Director,Officer	President and CEO	Direct	Sale	6,676	10.34	$69,029.84	1,161,344	4
2023-12-01	Lehman, David Aaron	Officer	General Counsel	Direct	Sale	3,809	10.34	$39,385.06	149,839	4
2023-12-01	Mckune, John	Officer	Interim CFO	Direct	Sale	942	10.34	$9,740.28	40,414	4
2023-11-22	Rose, Geoffrey Beran	Officer	Chief Commercial Officer	Direct	Sale	1,184	10.60	$12,550.40	249,469	4
2023-10-23	Rose, Geoffrey Beran	Officer	Chief Commercial Officer	Direct	Sale	1,184	8.35	$9,886.40	250,653	4
2023-09-22	Rose, Geoffrey Beran	Officer	Chief Commercial Officer	Direct	Sale	1,184	10.51	$12,443.84	251,837	4
2023-09-01	Sung, Derrick	Officer	Chief Financial Officer	Direct	Sale	4,219	10.01	$42,232.19	391,041	4
2023-09-01	Rose, Geoffrey Beran	Officer	Chief Commercial Officer	Direct	Sale	2,843	10.01	$28,458.43	253,021	4
2023-09-01	French, Glendon E. Iii	Director,Officer	President and CEO	Direct	Sale	6,527	10.01	$65,335.27	1,168,020	4
2023-09-01	Lehman, David Aaron	Officer	General Counsel	Direct	Sale	3,772	10.01	$37,757.72	153,648	4
2023-08-23	Rose, Geoffrey Beran	Officer	Chief Commercial Officer	Direct	Sale	1,184	10.54	$12,479.36	255,864	4
2023-07-20	French, Glendon E. Iii	Director,Officer	President and CEO	Direct	Sale	15,000	12.68	$190,200.00	1,174,547	4
2023-06-15	French, Glendon E. Iii	Director,Officer	President and CEO	Direct	Sale	10,000	12.68	$126,800.00	1,189,547	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

73.84%

Inst. Shares: 30,937,187

Shares Outstanding: 41,897,669

2025-12-31

77.70%

Inst. Shares: 31,611,344

Shares Outstanding: 40,685,934

2025-09-30

74.22%

Inst. Shares: 30,384,991

Shares Outstanding: 40,936,896

2025-06-30

84.00%

Inst. Shares: 33,961,562

Shares Outstanding: 40,429,655

2025-03-31

86.05%

Inst. Shares: 34,379,906

Shares Outstanding: 39,954,658

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	30,937,187	41,897,669	73.84%
2025-12-31	31,611,344	40,685,934	77.70%
2025-09-30	30,384,991	40,936,896	74.22%
2025-06-30	33,961,562	40,429,655	84.00%
2025-03-31	34,379,906	39,954,658	86.05%
2024-12-31	34,203,202	39,111,073	87.45%
2024-09-30	33,684,148	39,276,447	85.76%
2024-06-30	33,312,508	38,943,066	85.54%
2024-03-31	32,722,718	38,636,029	84.69%
2023-12-31	31,574,987	37,974,567	83.15%
2023-09-30	31,601,893	38,119,824	82.90%
2023-06-30	32,103,809	37,818,256	84.89%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Pulmonx Corp (LUNG) — SEC Financial Statements & Analysis

Pulmonx Corp (LUNG) is a surgical & medical instruments & apparatus company, incorporated in DE. Pulmonx Corp trades on Nasdaq as: LUNG. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Pulmonx Corp reported a -3.43% year-over-year revenue growth, a Gross Profit Margin of 77.06% (TTM), a Debt-to-Equity ratio of 1.93x, a Price-to-Sales (P/S) ratio of 0.63x (TTM), a Price-to-Book (P/B) ratio of 1.41x (TTM), at a market cap of $55.21M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -3.43%
Gross Profit Margin TTM: 77.06%
Debt To Equity: 1.93x
P/S TTM: 0.63x
P/B TTM: 1.41x
Market Cap: $55.21M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Pulmonx Corp in?

Pulmonx Corp (LUNG) operates in the Surgical & Medical Instruments & Apparatus industry.

What is LUNG's market cap?

Pulmonx Corp (LUNG) has a market capitalization of $55.21M as of 2026-06-30.

What exchange does LUNG trade on?

Pulmonx Corp (LUNG) trades on the Nasdaq.

Where is Pulmonx Corp incorporated?

Pulmonx Corp is incorporated in DE.

Pulmonx Corp

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Pulmonx Corp (LUNG) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

Pulmonx Corp (LUNG) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.